• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,100.47 109.25
( 0.14%)
Global Indices
Nasdaq
51,823.54 -118.08
(-0.23%)
Dow Jones
7,358.68 -19.81
(-0.27%)
Hang Seng
69,065.93 -3,300.41
(-4.56%)
Nikkei 225
10,515.14 -14.75
(-0.14%)
Forex
USD-INR
94.41 -0.14
(-0.15%)
EUR-INR
107.28 -0.07
(-0.07%)
GBP-INR
124.48 -0.08
(-0.06%)
JPY-INR
0.58 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Vivimed Labs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532660
INE526G01021
0.9167078
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VIVIMEDLAB
0
48.09
EPS(TTM)
Face Value()
Div & Yield %
0
2
0
 

Zenith Exports reports standalone net loss of Rs 0.12 crore in the March 2026 quarter
May 30,2026
Net loss of Zenith Exports reported to Rs 0.12 crore in the quarter ended March 2026 as against net profit of Rs 3.00 crore during the previous quarter ended March 2025. Sales declined 37.29% to Rs 13.10 crore in the quarter ended March 2026 as against Rs 20.89 crore during the previous quarter ended March 2025.

For the full year,net profit rose 33.92% to Rs 2.29 crore in the year ended March 2026 as against Rs 1.71 crore during the previous year ended March 2025. Sales declined 10.29% to Rs 64.68 crore in the year ended March 2026 as against Rs 72.10 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales13.1020.89 -37 64.6872.10 -10
OPM %-8.70-5.94 -0.20-6.23 -
PBDT0.14-0.26 LP 3.96-1.26 LP
PBT-0.09-0.47 81 3.25-2.08 LP
NP-0.123.00 PL 2.291.71 34